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Abstract
To generate high affinity antibodies during an immune response, B cells undergo somatic hypermutation (SHM) of their
immunoglobulin genes. Error-prone translesion synthesis (TLS) DNA polymerases have been reported to be responsible for
all mutations at template A/T and at least a fraction of G/C transversions. In contrast to A/T mutations which depend on
PCNA ubiquitination, it remains unclear how G/C transversions are regulated during SHM. Several lines of evidence indicate
a mechanistic link between the Fanconi Anemia (FA) pathway and TLS. To investigate the contribution of the FA pathway in
SHM we analyzed FancG-deficient B cells. B cells deficient for FancG, an essential member of the FA core complex, were
hypersensitive to treatment with cross-linking agents. However, the frequencies and nucleotide exchange spectra of SHM
remained comparable between wild-type and FancG-deficient B cells. These data indicate that the FA pathway is not
involved in regulating the outcome of SHM in mammals. In addition, the FA pathway appears dispensable for class switch
recombination.
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Introduction
Within the germinal center (GC), antigen activated B cells
undergo class switch recombination (CSR) and somatic hypermu-
tation (SHM). During CSR the immunoglobulin (Ig) heavy chain
constant region is replaced for a downstream constant region, to
generate an antibody with a different effector function. CSR
depends on the introduction of double strand breaks in two active
switch regions of the Ig heavy chain constant regions and involves
nonhomologous end-joining (NHEJ) to ligate the break sites. [1].
To generate high affinity antibody variants, GC B cells can
introduce point mutations into the variable region of their
rearranged immunoglobulin (Ig) genes. This process of SHM
occurs at an extraordinary rate of one in a thousand base pairs per
generation [2]. To model the underlying mechanism, error-prone
polymerases were postulated about half a century ago [3]. Yet,
only the last two decades revealed the existence of such DNA
polymerases. In contrast to replicative DNA polymerases, TLS
polymerases are highly mutagenic when replicating across
undamaged DNA [4,5]. At least polymerase g, Rev1 and to
some degree polymerase k have been related to SHM. Since each
polymerase displays its own mutation signature, alterations in the
nucleotide exchange spectrum can often be attributed retrospec-
tively to the absence of, or failure in activating specific
polymerases. For example, Rev1-deficient B cells display a
selective reduction of G/C to C/G transversions [6–8], a finding
consistent with the restricted dCMP transferase activity of Rev1
[9]. In contrast, the mutation spectra of polymerase g -deficient B
cells from human and mice lack a significant fraction of A/T
mutations [10–12]. While the lack of polymerase k had no effect
on SHM [13], polymerase k was found to generate A/T mutations
in the absence of polymerase g [14]. Recently, it has been
demonstrated that SHM at template A/T is regulated by site
specific monoubiquitination of proliferating cell nuclear antigen
(PCNA) at lysine 164 (PCNA-Ub). In agreement with an
important role for PCNA-Ub in recruiting and activating TLS
polymerases upon replication fork stalling [15–17], analysis of the
mutation spectra of mutated Ig genes in B cells from PCNA
K164R
knock-in mice revealed a selective 10-fold reduction of A/T
mutations [18,19]. Consistently, PCNA knock-out mice reconsti-
tuted with a PCNA
K164R transgene showed a reduction of A/T
mutations in Ig genes [20], suggesting that during SHM PCNA-
Ub recruits polymerase g and k to introduce mutations at
template A/T. The question remains, what are the molecular
prerequisites that stimulate error-prone polymerases like Rev1 to
establish transversions at template G/C?
Fanconi anemia (FA) is an autosomal recessive genetic disorder,
which at the cellular level is characterized by a hypersensitivity to
DNA cross-linking agents such as Cisplatin [21]. How the FA
pathway mediates resistance to cross-links is largely unknown.
Current models suggest that after replicative DNA polymerases
are stalled at a DNA cross-link, FANCD2 and FANCI become
monoubiquitinated by the FA core complex. The FA core
complex consists of eight essential FA proteins, FANCA, -B, -C,
-E, -F, -G, -L, -M, and two FA-Associated Proteins FAAP100 and
FAAP24. FANCD2 was shown to stimulate incision of one of the
strands containing the cross-link and to recruit TLS polymerases
to enable a direct replicative bypass [22]. In agreement, the TLS
polymerases Rev1 and Rev3 have been demonstrated to act
synergistically with the FA pathway for cross-link repair in chicken
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FANCD2 modifies the resulting double strand break to prevent
Ku70 from binding and activating NHEJ [24,25].
As the FA pathway has been associated with damage tolerant
TLS polymerases, including Rev1, we questioned whether this
pathway controls the outcome of SHM in mammals. Interestingly,
it has been reported that chicken DT40 B cells deficient for
members of the FA pathway show a decrease in SHM [23,26],
although the precise mechanism for the decrease in the
accumulation of non-templated mutations is currently unclear.
To determine the role of the FA pathway in SHM, we analyzed
SHM in FancG-deficient mice. In addition, given the inhibitory
action of FANCD2 on NHEJ we addressed whether the FA
pathway is involved in CSR.
Results and Discussion
Sensitivity of wild-type and FancG-deficient B cells to
cross-linking agents
To investigate the involvement of the FA core complex in SHM
we first determined if B cells of FancG-deficient mice display a FA
phenotype. Like cells derived from FA patients, mouse embryonic
fibroblasts from FancG-deficient mice are unable to monoubiqui-
nate FANCD2 and are highly sensitivity to cross-linking agents
such as Cisplatin [27]. To reveal the activity and specificity of the
FA pathway in resolving DNA cross-links in primary B cells, B cell
cultures from wild-type and FancG-deficient mice were established
and exposed to Cisplatin and UV-C. Compared to WT cells
FancG-deficient B cells were highly sensitive to Cisplatin, but not
to UV-C (Fig. 1). These data are in agreement with those of
fibroblast cell lines derived from FA patients and FA-deficient
mice. Apparently, the FA pathway is active in primary B cells and
plays a role in response to DNA cross-links.
Mutation frequencies in wild-type and FancG-deficient B
cells
To determine the contribution of the FA pathway in the
regulation of SHM, we sequenced the JH4 intronic region of GC
B cells sorted from the Peyer’s patches of nine FancG-deficient and
nine wild type control mice. By analyzing clonally unrelated
introns, 1356 mutations were found in 164 mutated intronic
sequences from wild-type B cells and 1392 mutations in 195
mutated intronic sequences from FancG-deficient B cells. In
contrast to previous observations made in FA-deficient chicken
DT40 B cells, which demonstrated reduced levels of SHM [23,26],
a high frequency of point mutations in somatically mutated Ig
genes of both, wild-type and FancG-deficient B cells was found
(Table 1). The range of SHM frequencies observed from the
individually analyzed mice is depicted in figure 2A. No significant
difference in accumulating somatic mutations between wild type
and FancG-deficient B cells was found (paired Student’s t-test,
p=0.3).
Point mutation spectra in wild-type and FancG-deficient
B cells
The decrease in non-templated mutations observed in FA-
deficient DT40 cells [23] may relate to impaired TLS activity.
Genetic studies have indicated a role for the TLS polymerase
Rev1 downstream of the FA pathway upon treatment with cross-
linking agents [23]. Furthermore the recruitment of Rev1 upon
UV treatment was reported to rely in part on the FA pathway
[28]. While DT40 B cells strongly depend on Rev1 for SHM [7],
SHM in mammals depends only partly on Rev1 [6,29]. However,
in both systems Rev1-deficient B cells display reduced frequencies
of G/C to C/G transversions during SHM [6,7,29]. Therefore, if
the FA pathway stimulates Rev1 during SHM, a reduction in these
mutations is expected in FancG-deficient B cells. To address
whether the FA pathway regulates TLS polymerases during SHM
in mammals, we analyzed the pattern of non-selected, nucleotide
substitutions in the non-transcribed strand of the JH4 intronic
region. The spectra of nucleotide substitutions were similar
between wild-type and FancG-deficient mice (x
2 test, p,0.01),
indicating that Rev1 and also other TLS polymerases involved in
mammalian SHM do not depend on the FA pathway to generate
mutations (Fig 2.). The decrease in non-templated mutations
found in FA-deficient DT40 cells [23] may relate to an interspecies
difference between avian and mammalian SHM. Alternatively, the
reduction in mutations observed in FA-deficient DT40 cells is not
a consequence of impaired TLS activity, but regulated at a
different level. Analysis of the nucleotide exchange pattern in FA-
deficient DT40 cells is required to distinguish between these
possibilities.
Class switch recombination in FancG-deficient B cells
Recently, it has been reported that double strand breaks created
at cross-links or abasic sites are modified by FANCD2 to prevent
Figure 1. FancG-deficient B cells are sensitive to DNA cross-linking agents. FancG-deficient (red) and wild-type (blue) B cells were
stimulated with LPS and exposed to increasing doses of either UV-C (left panel) or Cisplatin (right panel). The percentage of survival after four days of
culture is shown.
doi:10.1371/journal.pone.0015236.g001
FancG in SHM and CSR
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15236Ku70 from binding and activating NHEJ [24,25]. As CSR
depends on NHEJ, we questioned whether the FA pathway
regulates class switch recombination by inhibiting NHEJ. To
determine the capacity of wild-type and FancG-deficient B cells to
undergo CSR to IgG3 and IgG1, naı ¨ve B cells were cultured with
lipopolysacharide (LPS) in the absence or presence of interleukin-4
(IL-4), respectively (Fig. 3). Inactivation of FancG resulted in a
reduction of IgG3 class switched cells compared to wild-type cells.
However, as we did not observe a difference in class switching to
IgG1, the reduction in IgG3 switching may suggest an isotype-
specific role of FA in CSR. Alternatively, the FA pathway does not
play a direct role in CSR, but affects the switching process only
indirectly. Moreover, as the CSR frequencies did not increase in
FancG-deficient B cells, the formal possibility that the FA pathway
inhibits CSR by blocking NHEJ can be excluded.
Concluding remarks
In conclusion, our data indicate for the first time that SHM in
mammals is not regulated by the FA pathway. While mutations at
template A/T by polymerase g are regulated at the level of PCNA
ubiquitination, future studies will have to reveal the underlying
molecular mechanism how TLS polymerases like Rev1, involved
in the generation of G/C transversions become activated. The
normal switching activity to IgG1 and partial reduction to IgG3
suggests, that overall the FA pathway is dispensable for CSR.
Materials and Methods
Mice
The generation and genotyping of FancG-deficient mice has
been described elsewhere [27]. Mice were maintained on pure
FVB background at the animal facility of the Netherlands Cancer
Institute (Amsterdam, Netherlands). All experiments were ap-
proved by an independent animal ethics committee of the
Netherlands Cancer Institute (ID 08065 and ID 06003) and
executed according to national guidelines.
Isolation of germinal center B cells and mutation analysis
Germinal center (CD19+, PNA high, CD95+) B cells were
sorted from Peyer’s patches. Genomic DNA was extracted using
proteinase K treatment and ethanol precipitation. The JH4
39flanking intronic sequence of endogenous rearrangements of
VHJ558 family members were amplified during 40 cycles of PCR
using PFU Ultra polymerase (Stratagene) [30]. PCR products
were purified using the QIAquick Gel Extraction kit (Qiagen) and
cloned into the TOPO zero blunt vector (Invitrogen Life
Technologies) and sequenced on a 3730 DNA analyzer (Applied
Biosystems). Sequence alignment was performed using Seqman
software (DNAStar). Calculations exclude non-mutated sequences,
insertions and deletions. Clonally related sequences were counted
only once.
Class switch recombination
Naı ¨ve splenic B cells from three mice per genotype were
obtained by CD43 depletion using biotinylated anti CD43 (Clone
S7, BD Biosciences), and the IMag system (BD Biosciences), as
described by the manufacturer. Purified B cells were cultured at
10
5 cells/ml in 24 well plates in IMDM, 8% FCS, 50 mM2 -
mercapthoethanol, penicillin/streptomycin and 50 ug/ml E.Coli
LPS (055:B5, Sigma) either in the presence or absence of IL-4-
containing supernatants generated from X63-m-IL-4 cell cultures.
Flow cytometric analysis of surface Ig expression was performed
on day 4 of culture using goat anti mouse IgM-APC, IgG1-PE and
IgG3-PE (Southern Biotech). Data were analyzed using FlowJo 7.6
software.
Figure 2. Normal SHM in FancG-deficient B cells. A.) Unaltered accumulation of somatic mutations in germinal center B cells of FancG-deficient
mice. The frequency of SHM (% of mutations) as determined from 9 individual mice are shown per genotype (paired Student’s t-test, p=0.3). The
mean values and SD are indicated. B.) Normal nucleotide exchange pattern in hypermutated Ig genes of FancG-deficient germinal center B cells.
Values are expressed as the total number of mutations (left panel) and percentage of total mutations (right panel). Chi square testing did not reveal
any significant changes in the pattern (p,0.01).
doi:10.1371/journal.pone.0015236.g002
Table 1. Mutated JH4 intronic regions from wild-type and
FancG-deficient GC B cells.
WT FancG 2/2
number of mice 9 9
number of mutated sequences 164 195
total number of point mutations 1356 1392
total number of base pairs sequenced 81606 97418
Mutations/base pair (%) 1.7 1.4
doi:10.1371/journal.pone.0015236.t001
FancG in SHM and CSR
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Naı ¨ve splenic B cells were obtained and cultured as described
above. For UV-C irradiation, 10
5 B cells were irradiated in 0.5 ml
medium (254 nm, UV StratalinkerH 2400, Stratagene). Following
irradiation, cells were cultured in 1 ml complete medium and LPS.
For the survival upon Cisplatin induced DNA damage, 10
5 B cells
were grown in 1 ml complete medium and LPS in the continuous
presence of different doses of Cisplatin. For determining the
survival, B cells were harvested after four days of culture and live
(propidium iodine negative) B cells were counted by FACS. Data
were analyzed using FlowJo 7.6 software.
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